diagnostics
4 stories related to this topic, newest first.
manilatimes.netRural Health Gaps Limit Early Alzheimer's Detection
Rural communities face shortages of dementia specialists and limited access to diagnostic testing. New blood-based tests cleared by the Food and Drug Administration last year may reduce those barriers if Medicare coverage expands.
EuronewsRoche's pTau217 Blood Test Receives CE Mark for Use in Europe
Roche announced Tuesday that its Elecsys pTau217 test, the first blood test designed to signal and rule out Alzheimer’s disease, has been cleared for use across the European Union. Developed with Eli Lilly and Company, the test aims to speed diagnosis for millions facing lengthy…
cnbc.comRoche Agrees to Acquire PathAI for Up to $1.1 Billion
Roche has agreed to buy digital pathology company PathAI in a deal valued at up to $1.1 billion. The transaction comes as the pharmaceutical and diagnostics company expands its presence in artificial intelligence applications for pathology. Seekingalpha.com reported the agreement…
swissinfo.chRoche Reports Positive Trends in China and Improved Diagnostics Outlook for Second Half of 2026
A Roche executive indicated positive developments in the company's China operations. The diagnostics segment is expected to perform better in the second half of 2026 compared to the first. This outlook highlights ongoing progress in Roche's key markets and business segments.